. "P(NR9065)" . "V\u00E1gnerov\u00E1, Iva" . "Vancomycin-resistant enterococci; Epidemiology"@en . . . "500579" . . "Zdroje a cesty \u0161\u00ED\u0159en\u00ED vankomycin-rezistentn\u00EDch enterokok\u016F u hemato-onkologick\u00FDch pacient\u016F"@cs . "6"^^ . "Zdroje a cesty \u0161\u00ED\u0159en\u00ED vankomycin-rezistentn\u00EDch enterokok\u016F u hemato-onkologick\u00FDch pacient\u016F"@cs . "[8DAD1DE7DD6B]" . "Sources and pathways of spread of vancomycin-resistant enterococci in hemato-onkological patients"@en . . "Kol\u00E1\u0159, Milan" . . "CZ - \u010Cesk\u00E1 republika" . "Papajik, Tom\u00E1\u0161" . . "Biomedical Papers" . "8"^^ . "RIV/61989592:15110/06:00003150" . "Recently, the importance of gram-positive, often multiresistant, bacteria, bacteria in the etiopathogenesis of - particularly nosocomial - infectious has increased. Among these, a significant role is played by vancomycin-resistant enterococci (VRE) present especially in patients with hematooncological diseases and those in intensive care units. Although they mostly represent mere colonization of the gastrointestinal tract they can also cause serious infections which are difficult to mamage therapeutically. VRE were first isolated in Europe in 1986 and a year later in the USA. At present, VRE are described in other countries in the world. In the Czech Republic, VRE were first reported at the Department of Hemato-oncology, University Hospital Olomouc (DHO) in 1997. The presented study aims at analysing an increased prevalence of VRE in the DHO patients in early 2005, assessing their importance and formulating a hypothesis concerning their source and potential transmission pathways as based"@en . . . . . . "Sauer, Pavel" . . "150" . "1213-8118" . "Faber, Edgar" . . "C\u00EDlem p\u0159edlo\u017Een\u00E9 studie byl rozbor v\u00FDskytu of vancomycin resistant enterococci (VRE) izolovan\u00FDch z r\u016Fzn\u00FDch druh\u016F klinick\u00E9ho materi\u00E1lu pacient\u016F of Department of Hemato-oncology (DHO), Teaching Hospital Olomouc, Czech Republic."@cs . "Sources and pathways of spread of vancomycin-resistant enterococci in hemato-onkological patients" . . "Hub\u00E1\u010Dek, Jarom\u00EDr" . "Raida, Lud\u011Bk" . "Slepi\u010Dkov\u00E1, Sabina" . "Sources and pathways of spread of vancomycin-resistant enterococci in hemato-onkological patients"@en . . "RIV/61989592:15110/06:00003150!RIV07-MZ0-15110___" . . . "15110" . "Sources and pathways of spread of vancomycin-resistant enterococci in hemato-onkological patients" . "117-120" . "1" . "Recently, the importance of gram-positive, often multiresistant, bacteria, bacteria in the etiopathogenesis of - particularly nosocomial - infectious has increased. Among these, a significant role is played by vancomycin-resistant enterococci (VRE) present especially in patients with hematooncological diseases and those in intensive care units. Although they mostly represent mere colonization of the gastrointestinal tract they can also cause serious infections which are difficult to mamage therapeutically. VRE were first isolated in Europe in 1986 and a year later in the USA. At present, VRE are described in other countries in the world. In the Czech Republic, VRE were first reported at the Department of Hemato-oncology, University Hospital Olomouc (DHO) in 1997. The presented study aims at analysing an increased prevalence of VRE in the DHO patients in early 2005, assessing their importance and formulating a hypothesis concerning their source and potential transmission pathways as based" . . "4"^^ .